Neumora Therapeutics (NMRA) Institutional Ownership → This AI Trade Machine Made 1,729%* (With 89% Wins) (From Prosper Trading Academy) (Ad) Free NMRA Stock Alerts $9.15 +0.09 (+0.99%) (As of 04/26/2024 ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for Neumora Therapeutics (NASDAQ:NMRA)CurrentInstitutional OwnershipPercentage47.65%Number ofInstitutional Buyers(last 12 months)14TotalInstitutional Inflows(last 12 months)$173.26MNumber ofInstitutional Sellers(last 12 months)0 Get NMRA Insider Trade Alerts Want to know when executives and insiders are buying or selling Neumora Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data NMRA Institutional Buying and Selling by Quarter Ad Prosper Trading AcademyThis AI Trade Machine Made 1,729%* (With 89% Wins)This A.I. trading software called out an options trade the other day with a nearly perfect historical win rate… And a cumulative gain of 1729%. How does it all work?Click Here To Get Your Free Copy Neumora Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails4/23/2024 Addis & Hill Inc314,821$4.19M3.6%N/A0.198% 4/22/2024 Windmill Hill Asset Management Ltd26,121$359K0.1%N/A0.016% 2/14/2024Avidity Partners Management LP1,990,632$33.94M1.2%+10.6%1.304% 2/13/2024Tower Research Capital LLC TRC 2,558$44K0.0%N/A0.002% 2/6/2024 Amalgamated Bank1,709$29K0.0%N/A0.001% 2/1/2024New York State Common Retirement Fund6,900$118K0.0%N/A0.005% 1/30/2024Strs Ohio3,200$54K0.0%N/A0.002% 1/12/2024SG Americas Securities LLC6,308$108K0.0%N/A0.004% 12/6/2023Citigroup Inc.14,416$203K0.0%N/A0.009% 11/15/2023Laurion Capital Management LP21,557$304K0.0%N/A0.014% 11/14/2023Soros Fund Management LLC10,000$141K0.0%N/A0.007% 11/14/2023Avidity Partners Management LP1,800,000$25.40M1.0%N/A1.179% 11/13/2023FMR LLC5,624,353$79.36M0.0%N/A3.683% 11/9/2023Johnson & Johnson912,128$12.87M4.7%N/A0.597% 10/23/2023 WELLCOME TRUST LTD THE as trustee of the WELLCOME TRUST3,309,124$46.69M0.6%N/A2.178% (Data available from 1/1/2016 forward) NMRA Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of NMRA shares? During the previous two years, 14 institutional investors and hedge funds held shares of Neumora Therapeutics. The most heavily invested institutionals were FMR LLC ($79.36M), WELLCOME TRUST LTD THE as trustee of the WELLCOME TRUST ($46.69M), Avidity Partners Management LP ($33.94M), Johnson & Johnson ($12.87M), Addis & Hill Inc ($4.19M), Windmill Hill Asset Management Ltd ($359K), and Laurion Capital Management LP ($304K).Learn more on NMRA's institutional investors. What percentage of Neumora Therapeutics stock is owned by institutional investors? 47.65% of Neumora Therapeutics stock is owned by institutional investors. Learn more on NMRA's institutional investor holdings. Which institutional investors have been buying Neumora Therapeutics stock? Of the 14 institutional investors that purchased Neumora Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: FMR LLC ($5.62M), WELLCOME TRUST LTD THE as trustee of the WELLCOME TRUST ($3.31M), Avidity Partners Management LP ($1.99M), Johnson & Johnson ($912.13K), Addis & Hill Inc ($314.82K), Windmill Hill Asset Management Ltd ($26.12K), and Laurion Capital Management LP ($21.56K). How much institutional buying is happening at Neumora Therapeutics? Institutional investors have bought a total of 12,243,827 shares in the last 24 months. This purchase volume represents approximately $173.26M in transactions. Related Companies: ADMA Biologics Institutional Ownership Inhibrx Institutional Ownership 4D Molecular Therapeutics Institutional Ownership Ginkgo Bioworks Institutional Ownership Cidara Therapeutics Institutional Ownership Tarsus Pharmaceuticals Institutional Ownership Beam Therapeutics Institutional Ownership Scholar Rock Institutional Ownership Autolus Therapeutics Institutional Ownership Fusion Pharmaceuticals Institutional Ownership This page (NASDAQ:NMRA) was last updated on 4/28/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyHe Is Giving Away BitcoinCrypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressThe A.I. story nobody is telling you (Read ASAP)TradeSmithMan Who Predicted 2008: “This Will be Worse.”AltimetryWhy Big Pharma is Investing Billions in This BiotechBehind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Neumora Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
